Literature DB >> 22893349

Monitoring of international normalized ratios: comparison of community nurses with family physicians.

Max A Levine1, Wei Shao, Douglas Klein.   

Abstract

OBJECTIVE: To determine whether community-based, nurse-led monitoring of the international normalized ratio (INR) in patients requiring long-term warfarin therapy was comparable to traditional physician monitoring.
DESIGN: A retrospective cohort analysis of patients taking long-term warfarin therapy.
SETTING: The study used data gathered from 3 family medicine clinics in a primary care network in Edmonton, Alta. PARTICIPANTS: Medical records of patients currently taking warfarin were examined. INTERVENTION: Implementation of nurse-led monitoring in a primary care network in place of standard family physician INR monitoring. MAIN OUTCOME MEASURES: The degree of INR control before and after the implementation of nurse-run INR monitoring was assessed. The average proportion of time spent outside of therapeutic INR ranges, as well as the average number of days between successive INR readings, was calculated and compared. The degree of control placed patients into either a good-control group (out of range ≤ 25% of the time) or a moderate-control group (out of range > 25% of the time) and these groups were compared.
RESULTS: Before nurse monitoring, INR values were out of range 20.4% of the time; after nurse monitoring they were out of range 19.2% of the time (P = .115); the time between sequential INR readings also did not differ before and after implementation of nurse monitoring (23.9 vs 21.6 days, P = .789).
CONCLUSION: Nurse-led monitoring of INR is as effective as traditional physician monitoring. Advantages of nurse-led monitoring might include freeing family physicians to see more patients or to spend less time at work. It might also represent potential cost savings.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22893349      PMCID: PMC3419004     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  18 in total

Review 1.  Effect of study setting on anticoagulation control: a systematic review and metaregression.

Authors:  Carl van Walraven; Alison Jennings; Natalie Oake; Dean Fergusson; Alan J Forster
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

2.  Comparison of anticoagulation clinic patient outcomes with outcomes from traditional care in a family medicine clinic.

Authors:  M A Chamberlain; N A Sageser; D Ruiz
Journal:  J Am Board Fam Pract       Date:  2001 Jan-Feb

3.  Anticoagulation monitoring by an anticoagulation service is more cost-effective than routine physician care.

Authors:  Faisal Aziz; Mary Corder; Jaclyn Wolffe; Anthony J Comerota
Journal:  J Vasc Surg       Date:  2011-07-13       Impact factor: 4.268

4.  The safety and effectiveness of a nurse-led anticoagulant service.

Authors:  Carole A Connor; Chris C Wright; Christopher D Fegan
Journal:  J Adv Nurs       Date:  2002-05       Impact factor: 3.187

5.  Effect of a centralized clinical pharmacy anticoagulation service on the outcomes of anticoagulation therapy.

Authors:  Daniel M Witt; Melanie A Sadler; Roberta L Shanahan; Georgann Mazzoli; Donald J Tillman
Journal:  Chest       Date:  2005-05       Impact factor: 9.410

6.  The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US.

Authors:  Patrick W Sullivan; Thomas W Arant; Samuel L Ellis; Heather Ulrich
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

7.  Comparison of an anticoagulation clinic with usual medical care: anticoagulation control, patient outcomes, and health care costs.

Authors:  E Chiquette; M G Amato; H I Bussey
Journal:  Arch Intern Med       Date:  1998 Aug 10-24

8.  Cost-effectiveness of two models of management for patients on chronic warfarin therapy--a Markov model analysis.

Authors:  Joyce H S You; Fredric W H Chan; Raymond S M Wong; Gregory Cheng
Journal:  Thromb Haemost       Date:  2003-12       Impact factor: 5.249

9.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

10.  Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis.

Authors:  Deborah A Cios; William L Baker; Stephen D Sander; Olivia J Phung; Craig I Coleman
Journal:  Am J Health Syst Pharm       Date:  2009-05-15       Impact factor: 2.637

View more
  4 in total

1.  Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50-70 Years.

Authors:  Jun Yu; Wei Wang
Journal:  Front Cardiovasc Med       Date:  2022-05-31

2.  American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy.

Authors:  Daniel M Witt; Robby Nieuwlaat; Nathan P Clark; Jack Ansell; Anne Holbrook; Jane Skov; Nadine Shehab; Juliet Mock; Tarra Myers; Francesco Dentali; Mark A Crowther; Arnav Agarwal; Meha Bhatt; Rasha Khatib; John J Riva; Yuan Zhang; Gordon Guyatt
Journal:  Blood Adv       Date:  2018-11-27

3.  Time in therapeutic range: Warfarin anticoagulation for atrial fibrillation in a community-based practice.

Authors:  Derek Gateman; Melissa Elizabeth Trojnar; Gina Agarwal
Journal:  Can Fam Physician       Date:  2017-10       Impact factor: 3.275

4.  A Pharmacist-Led Point-of-Care INR Clinic: Optimizing Care in a Family Health Team Setting.

Authors:  Jennifer Rossiter; Gursharan Soor; Deanna Telner; Babak Aliarzadeh; Jennifer Lake
Journal:  Int J Family Med       Date:  2013-12-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.